After a strong opening, Marvel Studios' Ant-Man and the Wasp: Quantumania suffered the biggest second-week drop in the history of the Marvel Cinematic Universe, and the Peyton Reed-directed threequel has taken another hit in its third weekend on general release.
Marvel's first Phase 5 movie took in $12 million at the domestic box office - a 61% decline from last weekend. As things stand, Ant-Man 3 could finish its run with a global total of just under or over $500 million, which would make it the lowest earner of the franchise.
Some analysts have been trying to put a positive spin on these numbers, but there's no getting away from how disappointing this performance is. Many major studio blockbusters tend to be critic proof, but that hasn't proven to be the case for the MCU films (Eternals also underperformed), with negative reviews and poor word-of-mouth clearly impacting ticket sales.
Much better news for MGM's Creed III, which has punched its way to $58.6 million domestic and has passed $100M worldwide, taking the No. 1 spot from Quantumania.
Have you been to see Ant-Man 3? If so, are you surprised by this update? Drop us a comment down below.
In Ant-Man and the Wasp: Quantumania, Super-Hero partners Scott Lang (Paul Rudd) and Hope van Dyne (Evangeline Lilly) return to continue their adventures as Ant-Man and the Wasp. Together, with Hope’s parents Janet van Dyne (Michelle Pfeiffer) and Hank Pym (Michael Douglas), and Scott’s daughter Cassie Lang (Kathryn Newton), the family finds themselves exploring the Quantum Realm, interacting with strange new creatures and embarking on an adventure that will push them beyond the limits of what they thought possible.
Directed by Peyton Reed and produced by Kevin Feige and Stephen Broussard, Ant-Man and The Wasp: Quantumania also stars Jonathan Majors as Kang, David Dastmalchian as Veb, Katy O'Brian as Jentorra, William Jackson Harper as Quaz and Bill Murray as Lord Krylar.